Abstract
Introduction

Diseases associated with the calcium-sensing receptor include both loss-of-function and gain-of-function disorders. Loss-of-function disorders are associated with hypercalcemia, while gain-of-function disorders are associated with hypocalcemia (1). The best characterized disease that is associated with loss-of-function of the calcium-sensing receptor is familial benign hypercalcemia, an autosomal dominant disorder characterized by lifelong hypercalcemia
. Disor (4) (5) (6) . Considering autoimmune hypoparathyroidism, the role of anti-calcium sensor autoimmunity has been challenged (7) , but it has also been shown that detection of antibodies against the receptor is influenced by the assay system used (6) . Only a few cases of autoimmune acquired hypercalcemia have been reported, and never in the context of well characterized autoimmune polyglandular syndrome (8) (9) (10) . Here, we report a case of hyperparathyroidism associated with anti-calcium-sensing receptor autoantibodies in a patient with type 1 diabetes and Graves' disease. 
T a b l e 1 . Au t o a n t i b o d i e s
T a b l e 2 . B i o l o g i c a l Ch a r a c t e r i s t i c s o f t h e P a t i e n t consent was obtained from the patient.
Materials and Methods
Detection of autoantibodies against parathyroid tissue
The indirect immunofluorescence (IIF) technique has been described elsewhere (5 
Detection of autoantibodies against the calcium sensing receptor
The method has been described elsewhere (5, 12 
Results
As shown in Fig. 1 The immunoblotting using the extracellular domain of the protein, allowed the detection of autoantibodies against the calcium-sensing receptor (Fig. 2 
). This reactivity was detected in both sera obtained at 2 years of interval. The specificity of the technique was assessed by a negative reaction using sera obtained from a patient with no hypoparathyroidism and from a patient suffering from an autoimmune polyglandular syndrome type II with no hypoparathyroidism.
Discussion
In this patient primary hyperparathyroidism was diagnosed on the basis of persistent, modest, hypercalcemia associated with inappropriate serum PTH concentration and hypercalciuria (13, 14 (5) .
The negative result of the second immunofluorescence should also be interpreted in the context of decreasing titers of autoantibodies as exemplified by decreased titers of anti-GAD and anti-TSH-receptor autoantibodies.
There have been only rare cases of hyperparathyroidism associated with anti calcium-sensing receptor autoantibodies (8) (9) (10) . In those patients hyperparathyroidism was frequently associated with various immune diseases such as rheumatoid arthritis and autoimmune hypophysitis (9) , thyroiditis or celiac disease in two families with multiple cases (8) (18) . In this work, it was suggested anticalcium-sensing receptor autoantibodies exert greater effects
F i g u r e 1 . De t e c t i o n o f h u ma n a n t i -p a r a t h y r o i d a Ab s b y a n i n d i r e c t i mmu n o f l u o r e s c e n c e t e c h n i q u e u s i n g c r y o s t a t s e ct i o n s o f h u ma n p a r a t h y r o i d g l a n d . Ho mo g e n e o u s c y t o p l a smi c s t a i n i n g o f t h e p a r a t h y r o i d c h i e f c e l l s wa s o b s e r v e d wi t h t h e s e r u m o f t h e p a t i e n t ( A) . T h e c o n t r o l s e r a p r o d u c e d l i t t l e o r n o s t a i n i n g ( B ) P h o t o mi c r o g r a p h s × 2 0 0 .
F i g u r e 2 . I mmu n o b l o t s o f s e r a u s i n g t h e e x t r a c e l l u l a r d o ma i n o f t h e Ca S R. T h e ma i n r e a c t i v i t y wa s o b s e r v e d wi t h a 7 0 k Da p r o t e i n c o r r e s p o n d i n g t o t h e e x t r a c e l l u l a r d o ma i n o f t h e Ca S R. Mo u s e mo n o c l o n a l a n t i b o d y t o t h e Ca S R ( ADD) ( l a n e 1 ) , p o s i t i v e s e r a f r o m AH ( l a n e 2 ) , n e g a t i v e c o n t r o l s e r a ( l a n e 3 ) , n e g a t i v e s e r a f r o m a p a t i e n t s u f f e r i n g f r o m a n a u t o i mmu n e p o l y g l a n d u l a r s y n d r o me t y p e I I wi t h n o h y p o p a r a t h y r o i d i s m ( l a n e 4 ) . Mo l e c u l a r ma r k e r s a r e i n c l u d e d o n t h e r i g h t .
on the parathyroid than on the kidney. 
